BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8801857)

  • 1. Hepatitis A and vaccination.
    Teuwen DE
    Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
    [No Abstract]   [Full Text] [Related]  

  • 2. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis A vaccine: which dose is best?
    Lonergan G
    JAMA; 1995 Apr; 273(13):999-1000. PubMed ID: 7897815
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis A vaccine].
    Mussa GC; Borgione S; Mussa F; Silvestro L
    Minerva Pediatr; 1995 Nov; 47(11):439-44. PubMed ID: 8684338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis A prevention by vaccination].
    Busch N
    Dtsch Med Wochenschr; 1998 Aug; 123(33):988. PubMed ID: 9739348
    [No Abstract]   [Full Text] [Related]  

  • 7. Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects.
    Ackerman Z; Ablin J; Shouval D
    Am J Gastroenterol; 1996 Feb; 91(2):413. PubMed ID: 8607537
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998.
    Deshaies D; Dion R; Valiquette L; Auger N
    Can Commun Dis Rep; 1998 Sep; 24(18):145-51. PubMed ID: 9780447
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis A vaccines.
    Wkly Epidemiol Rec; 2000 Feb; 75(5):38-44. PubMed ID: 10693358
    [No Abstract]   [Full Text] [Related]  

  • 10. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
    Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
    Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks.
    Just M; Berger R; Dreschsler H; Brantschen S; Glück R
    Vaccine; 1992; 10(11):737-9. PubMed ID: 1441728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with an inactivated hepatitis A vaccine.
    Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis A: is universal vaccination justified in Mexico?].
    Kershenobich D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S69-70. PubMed ID: 9102786
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis A vaccine for secondary hepatitis A infection.
    Monto AS; Victor JC
    Lancet; 1999 Jul; 354(9175):341-2; author reply 342-3. PubMed ID: 10440344
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A vaccine for secondary hepatitis A infection.
    Bell BP; Margolis HS
    Lancet; 1999 Jul; 354(9175):341; author reply 342-3. PubMed ID: 10440343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.